Holen Sie sich die Stockscreener-App
3.85
4.94%
-0.20
Handel nachbörslich:
3.85
Schlusskurs vom Vortag:
$4.05
Offen:
$4.04
24-Stunden-Volumen:
396.50K
Relative Volume:
0.72
Marktkapitalisierung:
$267.96M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-2.5667
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+2.67%
1M Leistung:
+2.80%
6M Leistung:
-33.28%
1J Leistung:
-49.48%
1-Tages-Spanne:
$3.84
$4.07
1-Wochen-Bereich:
$3.61
$4.075
52-Wochen-Spanne:
$3.49
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.85 | 274.23M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
291.25 | 46.74B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
63.34 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.65 | 11.43B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.38 | 8.38B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Does Health Catalyst Inc. stock pay reliable dividendsExceptional earning trajectories - jammulinksnews.com
What analysts say about Health Catalyst Inc. stockGame-changing capital returns - Autocar Professional
What drives Health Catalyst Inc. stock priceSuperior stock growth - Autocar Professional
Is Health Catalyst Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com
How to Take Advantage of moves in (HCAT) - news.stocktradersdaily.com
Health Catalyst Inc. Stock Analysis and ForecastRapid market gains - jammulinksnews.com
Empowering Growth: Care Coordination Prioritization Market - openPR.com
Health Catalyst (HCAT) Stock Sees 6.6% Increase Amid Earnings OptimismNews and Statistics - IndexBox
Why Health Catalyst (HCAT) Stock Is Up Today - Yahoo Finance
Health Catalyst Announces Q2 2025 Earnings Release and Conference Call on August 7, 2025 - AInvest
Why Health Catalyst Inc. stock is on top investor watchlistsRisk Adjusted Stock Signals - Newser
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025 - The Manila Times
Health Catalyst, Inc. to Announce Q2 2025 Operating Results and Host Conference Call on August 7 - Quiver Quantitative
Health Catalyst Earnings: Q2 2025 Results Coming August 7Key Financial Updates Expected - Stock Titan
AI in Patient Engagement Market Set to Witness Significant - openPR.com
What makes Health Catalyst Inc. stock price move sharply2x Return Forecast - Newser
Why Health Catalyst Inc. stock attracts strong analyst attentionHigh Return Investment Tips - Newser
How Health Catalyst Inc. stock performs during market volatilityAlpha Stock Ideas - Newser
Health Catalyst stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com Australia
Learn to Evaluate (HCAT) using the Charts - news.stocktradersdaily.com
Health Catalyst shareholders approve all proposals at annual meeting - Investing.com Australia
Health Catalyst shareholders approve all proposals at annual meeting By Investing.com - Investing.com India
Health Catalyst Stockholders Approve Key Governance Changes - TipRanks
Evercore ISI Group Lowers Health Catalyst's Price Target to $4.00 - AInvest
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Health Catalyst's AI Play on Databricks: A Blueprint for Healthcare IT Dominance - AInvest
Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace | HCAT Stock News - GuruFocus
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):